中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 9
Sep.  2021
Turn off MathJax
Article Contents

Postoperative complications of ex vivo liver resection combined with autologous liver transplantation in treatment of advanced hepatic alveolar echinococcosis at high altitude and related prevention and treatment strategies

DOI: 10.3969/j.issn.1001-5256.2021.09.029
Research funding:

Project of Echinococcosis Prevention and Control with Special Fund for Major Public Health in Qinghai Province in 2020 (2305999901-1073)

  • Received Date: 2021-01-29
  • Accepted Date: 2021-04-12
  • Published Date: 2021-09-20
  •   Objective  To investigate the postoperative complications of ex vivo liver resection combined with autologous liver transplantation in the treatment of end-stage hepatic alveolar echinococcosis at high altitude and related prevention and treatment strategies.  Methods  Surgical data and follow-up data were collected from 11 patients with end-stage hepatic alveolar echinococcosis who underwent autologous liver transplantation in Qinghai People's Hospital from January 2013 to March 2019, and intraoperative and postoperative conditions were analyzed.  Results  All 11 patients underwent autologous liver transplantation successfully, without intraoperative death, among whom 2(18.18%) underwent hemi-extracorporeal hepatectomy and 9 (81.82%) underwent total extracorporeal hepatectomy. For the reconstruction of the retrohepatic inferior vena cava, 2 patients (18.18%) underwent reconstruction with the autologous great saphenous vein, 4 patients (36.36%) underwent reconstruction with artificial vessels, and the autologous retrohepatic inferior vena cava was preserved in 5 patients (45.45%). For biliary reconstruction, 8 patients (72.73%) underwent choledochoenterostomy and 3 (27.27%) underwent choledochocholedochostomy. The main postoperative complications of the 11 patients included bleeding in 2 patients (18.18%), bile leakage and abdominal infection in 4 patients (36.36%), bilioenteric anastomotic stenosis in 1 patient (9.09%), thrombus in 2 patients (18.18%), pulmonary infection and pleural effusion in 2 patients (18.18%), and echinococcosis recurrence in 1 patient (9.09%). Of all 11 patients, 2 (18.18%) died during the perioperative period, and the other 9 patients (81.82%) were improved and discharged.  Conclusion  Bleeding, biliary complications, and infection are the main causes of death in patients undergoing autologous liver transplantation at high altitude. An accurate understanding of surgical indication, careful multidisciplinary evaluation before surgery, superb operation during surgery, standardized surgical procedures, and fine perioperative management are the key to reducing perioperative mortality, avoiding and reducing postoperative complications, and achieving good long-term survival in patients undergoing autologous liver transplantation.

     

  • loading
  • [1]
    LI T, CHEN X, ZHEN R, et al. Widespread co-endemicity of human cystic and alveolar echinococcosis on the eastern Tibetan Plateau, northwest Sichuan/southeast Qinghai, China[J]. Acta Trop, 2010, 113(3): 248-256. DOI: 10.1016/j.actatropica.2009.11.006.
    [2]
    WANG JL, LI TT, HUANG SY, et al. Major parasitic diseases of poverty in mainland China: Perspectives for better control[J]. Infect Dis Poverty, 2016, 5(1): 67. DOI: 10.1186/s40249-016-0159-0.
    [3]
    DEPLAZES P, RINALDI L, ROJAS CA, et al. Global distribution of alveolar and cystic echinococcosis[J]. Adv Parasitol, 2017, 95: 315-493. DOI: 10.1016/bs.apar.2016.11.001.
    [4]
    ZHAO J, DAWA Y, A K, et al. Association between echinococcosis-specific health literacy and behavioural intention to prevent echinococcosis among herdsmen on the Tibet Plateau in China: A cross-sectional study[J]. BMC Infect Dis, 2021, 21(1): 101. DOI: 10.1186/s12879-021-05775-8.
    [5]
    SALM LA, LACHENMAYER A, PERRODIN SF, et al. Surgical treatment strategies for hepatic alveolar echinococcosis[J]. Food Waterborne Parasitol, 2019, 15: e00050. DOI: 10.1016/j.fawpar.2019.e00050.
    [6]
    BRUNETTI E, KERN P, VUITTON DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans[J]. Acta Trop, 2010, 114(1): 1-16. DOI: 10.1016/j.actatropica.2009.11.001.
    [7]
    MIHMANLI M, IDIZ UO, KAYA C, et al. Current status of diagnosis and treatment of hepatic echinococcosis[J]. World J Hepatol, 2016, 8(28): 1169-1181. DOI: 10.4254/wjh.v8.i28.1169.
    [8]
    PARSAK CK, DEMIRYUREK HH, INAL M, et al. Alveolar hydatid disease: Imaging findings and surgical approach[J]. Acta Chir Belg, 2007, 107(5): 572-577. DOI: 10.1080/00015458.2007.11680128.
    [9]
    GUO YM, ZHU WJ, ZHAO SY, et al. Surgical treatment strategy for complex hepatic echinococcosis: A review[J]. Chin J Schisto Control, 2018, 30(6): 705-708. DOI: 10.16250/j.32.1374.2018169.

    郭亚民, 朱文君, 赵顺云, 等. 复杂性肝棘球蚴病外科治疗策略研究进展[J]. 中国血吸虫病防治杂志, 2018, 30(6): 705-708. DOI: 10.16250/j.32.1374.2018169.
    [10]
    KERN P, WEN H, SATO N, et al. WHO classification of alveolar echinococcosis: Principles and application[J]. Parasitol Int, 2006, 55 (Suppl): s283-s287. DOI: 10.1016/j.parint.2005.11.041.
    [11]
    Chinese Doctor Association, Chinese College of Surgeons(CCS), Chinese Committee for Hadytidology(CCH). Expert consensus on diagnosis and treatment of hepatic cystic and alveolar echinococcosis (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 711-721. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.002.

    中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.002.
    [12]
    SULIMA M, NAHORSKI W, GORYCKI T, et al. Ultrasound images in hepatic alveolar echinococcosis and clinical stage of the disease[J]. Adv Med Sci, 2019, 64(2): 324-330. DOI: 10.1016/j.advms.2019.04.002.
    [13]
    YE QF, LI X, FAN XL, et al. Research on the indications of half in situ or ex situ liver resection and liver autotransplantation: A report 36 cases[J]. Chin J Pract Surg, 2014, 34(8): 749-753. DOI: 10.7504/CJPS.ISSN1005-2208.2014.08.21.

    叶啟发, 李弦, 范晓礼, 等. 半离体或离体肝切除联合自体肝移植适应证探讨(附36例报告)[J]. 中国实用外科杂志, 2014, 34(8): 749-753. DOI: 10.7504/CJPS.ISSN1005-2208.2014.08.21.
    [14]
    AJI T, DONG J, SHAO Y, et al. Ex vivo liver resection and autotransplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis[J]. J Hepatol, 2018, 69(5): 1037-1046. DOI: 10.1016/j.ijid.2018.11.016.
    [15]
    SHI ZR, YAN LN, LI B, et al. Evaluation of standard liver volume formulae for Chinese adults[J]. World J Gastroenterol, 2009, 15(32): 4062-4066. DOI: 10.3748/wjg.15.4062.
    [16]
    SHEN S, QIU Y, YANG X, et al. Remnant liver-to-standard liver volume ratio below 40% is safe in ex vivo liver resection and autotransplantation[J]. J Gastrointest Surg, 2019, 23(10): 1964-1972. DOI: 10.1007/s11605-018-4022-4.
    [17]
    YANG X, QIU Y, HUANG B, et al. Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: A study of 31 cases[J]. Am J Transplant, 2018, 18(7): 1668-1679. DOI: 10.1111/ajt.14621.
    [18]
    PICHLMAYR R, BRETSCHNEIDER HJ, KIRCHNER E, et al. Ex situ operation on the liver. A new possibility in liver surgery[J]. Langenbecks Arch Chir, 1988, 373(2): 122-126. DOI: 10.1007/BF01262775.
    [19]
    KATO T, HWANG R, LIOU P, et al. Ex vivo resection and autotransplantation for conventionally unresectable tumors - an 11-year single center experience[J]. Ann Surg, 2020, 272(5): 766-772. DOI: 10.1097/SLA.0000000000004270.
    [20]
    HWANG R, LIOU P, GRIESEMER A, et al. Ex vivo tumor resection and intestinal autotransplantation - a single center 10-year experience[J]. Transplantation, 2019, 103: s25. DOI: 10.1097/01.tp.0000575548.39884.0b.
    [21]
    HWANG R, LIOU P, KATO T. Ex vivo liver resection and autotransplantation: An emerging option in selected indications[J]. J Hepatol, 2018, 69(5): 1002-1003. DOI: 10.1016/j.jhep.2018.09.005.
    [22]
    WEN H, DONG JH, ZHANG JH, et al. Ex vivo liver resection and autotransplantation for end-stage alveolar echinococcosis: A case series[J]. Am J Transplant, 2016, 16(2): 615-624. DOI: 10.1111/ajt.13465.
    [23]
    YANG XW, HUANG B, QIU YW, et al. Ex vivo liver resection followed by autotransplantation in the treatment of advanced hepatic alveolar echinococcosis: A report of 21 cases[J]. Chin J Bases and Clin Gen Surg, 2017, 24(6): 685-690. DOI: 10.7507/1007-9424.201704040.

    杨先伟, 黄斌, 邱逸闻, 等. 离体肝切除联合自体肝移植治疗晚期肝泡型包虫病21例报道[J]. 中国普外基础与临床杂志, 2017, 24(6): 685-690. DOI: 10.7507/1007-9424.201704040.
    [24]
    GAO C, YE CJ, GUO YM, et al. Analysis of postoperative complications after autologous liver transplantation in hepatic alveolar echinococcosis patients from plateau area[J]. Organ Transplantion, 2016, 7(6): 449-453. DOI: 10.3969/j.issn.1674-7445.2016.06.007.

    高超, 叶成杰, 郭亚民, 等. 高原肝泡状棘球蚴病自体肝移植术后并发症的分析[J]. 器官移植, 2016, 7(6): 449-453. DOI: 10.3969/j.issn.1674-7445.2016.06.007.
    [25]
    YU ZS, JIANG Y, CAI QC, et al. Complications after liver transplantation[J]. Chin J Tissue Engineer Res, 2013, 17 (18): 3275-3282. DOI: 10.3969/j.issn.2095-4344.2013.18.007.

    余忠山, 江艺, 蔡秋程, 等. 肝移植后的并发症[J]. 中国组织工程研究, 2013, 17(18): 3275-3282. DOI: 10.3969/j.issn.2095-4344.2013.18.007.
    [26]
    YE XZH, WU XM, MA RH, et al. Autologous liver transplantation for the treatment of end-stage alveolar echinococcosis in plateau area[J]. Chin J Hepatobiliary Surg, 2014, 20 (2): 148-150. DOI: 10.3760/cma.j.issn.1007-8118.2014.02.018.

    叶谢智华, 吴新民, 马荣花, 等. 高原地区自体肝移植治疗终末期泡型肝包虫病[J]. 中华肝胆外科杂志, 2014, 20(2): 148-150. DOI: 10.3760/cma.j.issn.1007-8118.2014.02.018.
    [27]
    CHENG HH, A XR, WANG LP. Changes of vascular endothelial cell function in healthy people at different altitudes[J]. Lab Med, 2010, 25 (8): 647-648. DOI: 10.3969/j.issn.1673-8640.2010.08.020.

    程海花, 阿祥仁, 王立萍. 不同海拔地区健康人群血管内皮细胞功能指标的变化[J]. 检验医学, 2010, 25(8): 647-648. DOI: 10.3969/j.issn.1673-8640.2010.08.020.
    [28]
    ZENG DF, WANG J. Traumatic coagulation abnormalities and trauma induced coagulopathy in high altitude environment[J/CD]. Chin J Diag (Electronic Edition), 2020, 8(3): 168-170. DOI: 10.3877/cma.j.issn.2095-655X.2020.03.005.

    曾东风, 王劲. 高原环境下创伤后凝血功能异常与创伤性凝血病[J/CD]. 中华诊断学电子杂志, 2020, 8(3): 168-170. DOI: 10.3877/cma.j.issn.2095-655X.2020.03.005.
    [29]
    QIAN HG, GONG BCD, FAN JL, et al. Changes of coagulation function and its significance in patients with multiple organ dysfunction syndromes (MODS)after serious trauma at high altitude[J]. J High Altitude Med, 2011, 21 (3): 1-4. DOI: 10.3969/j.issn.1007-3809.2011.03.001.

    钱惠岗, 公保才旦, 樊建林, 等. 高原地区严重创伤后多脏器功能不全患者凝血功能的变化及意义[J]. 高原医学杂志, 2011, 21(3): 1-4. DOI: 10.3969/j.issn.1007-3809.2011.03.001.
    [30]
    ZHU ZD, DU GS, SHI BY, et al. Upper gastrointestinal bleeding after adults orthotopic liver transplantation[J]. J Clin Rehabil Tissue Eng Res, 2011, 15 (53): 9893-9896. DOI: 10.3969/j.issn.1673-8225.2011.53.004.

    朱志东, 杜国盛, 石炳毅, 等. 成人肝移植后的上消化道出血[J]. 中国组织工程研究与临床康复, 2011, 15(53): 9893-9896. DOI: 10.3969/j.issn.1673-8225.2011.53.004.
    [31]
    Branch of Organ Transplantation of Chinese Medical Association. Diagnosis and treatment specification for postoperative complications after liver transplantation in China (2019 edition)[J]. Ogran Transplantation, 2021, 12(2): 129-133. DOI: 10.3969/j.issn.1674-7445.2021.02.002.

    中华医学会器官移植学分会. 中国肝移植术后并发症诊疗规范(2019版)[J]. 器官移植, 2021, 12(2): 129-133. DOI: 10.3969/j.issn.1674-7445.2021.02.002.
    [32]
    LATTANZI B, OTT P, RASMUSSEN A, et al. Ischemic damage represents the main risk factor for biliary stricture after liver transplantation: A follow-up study in a danish population[J]. In Vivo, 2018, 32(6): 1623-1628. DOI: 10.21873/invivo.11423.
    [33]
    JUNG DH, IKEGAMI T, BALCI D, et al. Biliary reconstruction and complications in living donor liver transplantation[J]. Int J Surg, 2020, 82S: 138-144. DOI: 10.1016/j.ijsu.2020.04.069.
    [34]
    SIMOES P, KESAR V, AHMAD J. Spectrum of biliary complications following live donor liver transplantation[J]. World J Hepatol, 2015, 7(14): 1856-1865. DOI: 10.4254/wjh.v7.i14.1856.
    [35]
    AKAMATSU N, SUGAWARA Y, HASHIMOTO D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: A systematic review of the incidence, risk factors and outcome[J]. Transpl Int, 2011, 24(4): 379-392. DOI: 10.1111/j.1432-2277.2010.01202.x.
    [36]
    QIN YY, ZHOU D, WANG JD, et al. Management of biliary anastomotic stricture after liver transplantation: Experience from the University of Pittsburgh Transplant Institute[J]. Organ Transplantion, 2015, 6(6): 370-373. DOI: 10.3969/j.issn.1674-7445.2015.06.004.

    秦一雨, 周迪, 王健东, 等. 肝移植术后胆道吻合口狭窄处理方法探讨--来自美国匹兹堡大学移植研究所的经验[J]. 器官移植, 2015, 6(6): 370-373. DOI: 10.3969/j.issn.1674-7445.2015.06.004.
    [37]
    ZENG X, YANG X, YANG P, et al. Individualized biliary reconstruction techniques in autotransplantation for end-stage hepatic alveolar echinococcosis[J]. HPB (Oxford), 2020, 22(4): 578-587. DOI: 10.1016/j.hpb.2019.08.003.
    [38]
    CAI YS, LIU XW, XIAO H, et al. Biliary complications after liver transplantation: Diagnosis and treatments[J/CD]. Chin J Hepat Surg(Electronic Edition), 2018, 7(5): 391-395. DOI: 10.3877/cma.j.issn.2095-3232.2018.05.011.

    蔡云石, 刘雄威, 肖衡, 等. 肝移植术后胆道并发症的诊治[J/CD]. 中华肝脏外科手术学电子杂志, 2018, 7(5): 391-395. DOI: 10.3877/cma.j.issn.2095-3232.2018.05.011.
    [39]
    GUILLAUD A, PERY C, CAMPILLO B, et al. Incidence and predictive factors of clinically relevant bile leakage in the modern era of liver resections[J]. HPB (Oxford), 2013, 15(3): 224-229. DOI: 10.1111/j.1477-2574.2012.00580.x.
    [40]
    XIAO LN, LI X, GENG C, et al. Safety and effectiveness of endoscopic treatment for biliary tract complications after liver transplantation[J]. Chin J Bases and Clin Gen Surg, 2020, 27(1): 53-57. DOI: 10.7507/1007-9424.201909051.

    肖丽娜, 李骁, 耿冲, 等. 内镜治疗肝移植术后胆道并发症的疗效[J]. 中国普外基础与临床杂志, 2020, 27(1): 53-57. DOI: 10.7507/1007-9424.201909051.
    [41]
    KIM SI. Bacterial infection after liver transplantation[J]. World J Gastroenterol, 2014, 20(20): 6211-6220. DOI: 10.3748/wjg.v20.i20.6211.
    [42]
    LI H, JIA YN, HE Q, et al. Progress of immunosuppressant management, infection prevention and treatment after liver transplantation in severe liver disease[J]. Ogran Transplantation, 2020, 11(3): 344-349. DOI: 10.3969/j.issn.1674-7445.2020.03.004.

    李瀚, 贾亚男, 贺强, 等. 危重症肝病肝移植术后免疫抑制剂管理和感染的防治进展[J]. 器官移植, 2020, 11(3): 344-349. DOI: 10.3969/j.issn.1674-7445.2020.03.004.
    [43]
    WANG ZX, QIN LX. Prevention and treatment of complications after liver transplantation[J]. Chin J Bases and Clin Gen Surg, 2018, 25 (9): 1025-1030. DOI: 10.7507/1007-9424.201808051.

    王正昕, 钦伦秀. 肝移植术后并发症的防治现状及进展[J]. 中国普外基础与临床杂志, 2018, 25(9): 1025-1030. DOI: 10.7507/1007-9424.201808051.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(4)

    Article Metrics

    Article views (606) PDF downloads(31) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return